{{Rsnum
|rsid=2306604
|Gene=TFAM
|Chromosome=10
|position=60148692
|Orientation=minus
|GMAF=0.461
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 40.7 | 39.8
| HCB | 20.1 | 47.0 | 32.8
| JPT | 12.5 | 58.9 | 28.6
| YRI | 75.3 | 23.3 | 1.4
| ASW | 58.9 | 39.3 | 1.8
| CHB | 20.1 | 47.0 | 32.8
| CHD | 14.0 | 59.8 | 26.2
| GIH | 22.0 | 47.0 | 31.0
| LWK | 75.0 | 23.1 | 1.9
| MEX | 15.8 | 49.1 | 35.1
| MKK | 63.9 | 30.3 | 5.8
| TSI | 20.6 | 55.9 | 23.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=19925850
|Title=MITOCHONDRIAL TRANSCRIPTION FACTOR A VARIANTS AND THE RISK OF PARKINSON'S DISEASE
}}

{{PMID Auto
|PMID=20977898
|Title=Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese
}}

{{PMID|15464268}} Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease.

{{PMID|17497594}} Relationship between TFAM gene polymorphisms and endurance capacity in response to training.

{{PMID|17537576}} Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease.

{{PMID|18813964|OA=1
}} Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

{{PMID|18830724|OA=1
}} Assessment of Alzheimer's disease case-control associations using family-based methods.

{{PMID|20574532|OA=1
}} Intermediate phenotypes identify divergent pathways to Alzheimer's disease.

{{PMID|22361577|OA=1
}} PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

{{PMID Auto
|PMID=24184878
|Title=Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}